J. R. T DAVIDSON -
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, Department of Psychology, Duke University and Veterans Administration Medical Center, Durham, NC; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, SC; Department of Psychiatry, University of Miami, FL; and Ciba-Geigy Pharmaceuticals, Summit, NJ, USA
S. W BOOK -
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, Department of Psychology, Duke University and Veterans Administration Medical Center, Durham, NC; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, SC; Department of Psychiatry, University of Miami, FL; and Ciba-Geigy Pharmaceuticals, Summit, NJ, USA
J. T COLKET -
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, Department of Psychology, Duke University and Veterans Administration Medical Center, Durham, NC; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, SC; Department of Psychiatry, University of Miami, FL; and Ciba-Geigy Pharmaceuticals, Summit, NJ, USA
L. A TUPLER -
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, Department of Psychology, Duke University and Veterans Administration Medical Center, Durham, NC; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, SC; Department of Psychiatry, University of Miami, FL; and Ciba-Geigy Pharmaceuticals, Summit, NJ, USA
S ROTH -
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, Department of Psychology, Duke University and Veterans Administration Medical Center, Durham, NC; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, SC; Department of Psychiatry, University of Miami, FL; and Ciba-Geigy Pharmaceuticals, Summit, NJ, USA
D DAVID -
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, Department of Psychology, Duke University and Veterans Administration Medical Center, Durham, NC; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, SC; Department of Psychiatry, University of Miami, FL; and Ciba-Geigy Pharmaceuticals, Summit, NJ, USA
M HERTZBERG -
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, Department of Psychology, Duke University and Veterans Administration Medical Center, Durham, NC; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, SC; Department of Psychiatry, University of Miami, FL; and Ciba-Geigy Pharmaceuticals, Summit, NJ, USA
T MELLMAN -
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, Department of Psychology, Duke University and Veterans Administration Medical Center, Durham, NC; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, SC; Department of Psychiatry, University of Miami, FL; and Ciba-Geigy Pharmaceuticals, Summit, NJ, USA
J. C BECKHAM -
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, Department of Psychology, Duke University and Veterans Administration Medical Center, Durham, NC; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, SC; Department of Psychiatry, University of Miami, FL; and Ciba-Geigy Pharmaceuticals, Summit, NJ, USA
R. D SMITH -
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, Department of Psychology, Duke University and Veterans Administration Medical Center, Durham, NC; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, SC; Department of Psychiatry, University of Miami, FL; and Ciba-Geigy Pharmaceuticals, Summit, NJ, USA
R. M DAVISON -
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, Department of Psychology, Duke University and Veterans Administration Medical Center, Durham, NC; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, SC; Department of Psychiatry, University of Miami, FL; and Ciba-Geigy Pharmaceuticals, Summit, NJ, USA
R KATZ -
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, Department of Psychology, Duke University and Veterans Administration Medical Center, Durham, NC; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, SC; Department of Psychiatry, University of Miami, FL; and Ciba-Geigy Pharmaceuticals, Summit, NJ, USA
M. E FELDMAN -
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, Department of Psychology, Duke University and Veterans Administration Medical Center, Durham, NC; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, SC; Department of Psychiatry, University of Miami, FL; and Ciba-Geigy Pharmaceuticals, Summit, NJ, USA